NeuroOne Medical Technologies Corporation Fair Value, Debt Instrument, Valuation Techniques, Change in Technique, Quantification of Effect
NeuroOne Medical Technologies Corporation (NMTC) reported Fair Value, Debt Instrument, Valuation Techniques, Change in Technique, Quantification of Effect of -$1.25 million for the 9-month period ending 2020-06-30, per its 10-Q filed 2021-08-13.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisDebtInstrumentValuationTechniquesChangeInTechniqueQuantificationOfEffect · last filed 2021-08-13
- 2020-06-30: Fair Value, Debt Instrument, Valuation Techniques, Change in Technique, Quantification of Effect 9 month -$1.25M.
| Period end | Fair Value, Debt Instrument, Valuation Techniques, Change in Technique, Quantification of Effect 9 month |
|---|---|
| 2020-06-30 | -$1.25M 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |